| Study Period | 2019 - 2030 |
| Market Size (2025) | USD 1.88 Billion |
| Market Size (2030) | USD 2.80 Billion |
| CAGR (2025 - 2030) | 8.23 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Veterinary Intravenous Solutions Market Analysis
The Veterinary Intravenous Solutions Market size is estimated at USD 1.88 billion in 2025, and is expected to reach USD 2.80 billion by 2030, at a CAGR of 8.23% during the forecast period (2025-2030).
The market is anticipated to witness steady growth during the study period. Factors such as the rising prevalence of various veterinary disorders, advancements in veterinary medicine, and rising emphasis on animal care have facilitated the industry's growth. According to the American Veterinary Medical Association, around 78,177 veterinarians were engaged in veterinary clinical practice in 2022 compared to 73,900 in 2021. Thus, the rising emphasis on animal care and an increasing number of veterinarians are projected to support industry expansion during the study period.
The growing burden of various chronic and infectious diseases in animals is expected to fuel demand for veterinary intravenous solutions to maintain their well-being. For instance, according to an article published by Tropical Medicine and Infectious Disease1 in March 2023, bovine leptospirosis was a significant burden on cows, and the infection survived and propagated through alternative routes of transmission, such as sexual pathways.
Similarly, according to an article published by Livestock Science1 in May 2022, cows were at increased risk of developing infections during lactation, which also affected their milk quality. This increased risk of developing infections translated to a greater demand for intravenous solutions to provide tailored care for animals. Such trends are anticipated to accelerate market growth over the study period.
Moreover, the escalating demand for IV infusions in animals owing to several benefits associated with them has accelerated their adoption. Also, the high preference of veterinarians for IV solutions in emergencies to maintain accurate blood pressure and lower the chances of organ failure has bolstered the industry’s expansion.
The industry is also going to benefit from the evolving veterinary care landscape, rising investments in the veterinary care space, and increasing awareness about the correct implications of IV therapy in animals. For instance, in December 2022, Clinicians of the Cummings School of Veterinary Medicine launched an initiative to encourage veterinary hospitals to correctly use IV solutions for hospitalized patients. Under this initiative, the clinicians elaborated on the role of IV solutions in managing critically ill animals and also explained the harm of IV therapy in animals if not monitored properly. Thus, such initiatives from leading research institutes and universities have supported market growth.
Furthermore, the need for food safety and the focus on nutrition-rich food has become extremely valuable in the veterinary intravenous (IV) solutions market. Nutrition has a critical role in supporting the healthy health of animals, especially in those who are hospitalized and on IV fluid therapy. Various nutritional ingredients like amino acids, minerals, and vitamins can be supplemented via the intravenous route to attain complete nutrition.
The rising demand from end users for IV nutrition for animals has facilitated market players to introduce novel solutions. For instance, in May 2022, METEX NOOVISTAGO announced the launch of inneus, a new solution to support the intestinal health of poultry and piglet. The product is a combination of potent amino acids with polyphenols. Thus, the launch of such novel regimens is likely to foster industry uptake in the coming years.
Factors such as lack of awareness for IV solutions for animals and less penetration of animal care in low and middle-income countries are anticipated to hamper industry growth over the forecast period.
Veterinary Intravenous Solutions Market Trends
Companion Animal Segment is Expected to Hold a Major Market Share in the Global Veterinary Intravenous Solutions Market
The companion animal segment held the largest revenue share of the global veterinary intravenous solutions market, and it is projected to retain its dominance over the forecast period. The rising prevalence of various diseases in companion animals, coupled with recent advancements in veterinary medicine, are the factors driving segment expansion. Veterinary space has been consistently adopting novel approaches for managing animal health, including IV therapies, remote monitoring, and medical parameters monitoring.
Moreover, the segment growth is exponentially driven by the rising rate of pet ownership across the globe. For instance, according to Health for Animals, a global animal health association's data for 2022, the United States had a pet population of 150 million. The increasing number of pet owners contributes to the remarkable demand for IV veterinary solutions, as these solutions have a significant role in surgery and other animal health conditions.
Also, the increasing prevalence of chronic disorders in companion animals has highlighted the need for novel treatment regimes, including IV solutions/infusions. For instance, according to the journal published by MDPI in January 2022, the prevalence of chronic kidney disease was estimated to be around 1.0 to 3.0% in cats and 0.5 to 1.0% in dogs.
This increasing burden of chronic diseases among companion animals pushed companies and various organizations to innovate advanced solutions. For instance, in August 2023, Akston Biosciences Corporation announced its intentions to focus on animal health modalities. This step by the company is critical for the management of various infectious diseases in animals. Moreover, in September 2023, the Veterinary Emergency Group (VEG) launched a VEG Blood Bank program to collect and store dog blood. This collected blood will be used by veterinary clinics to save other dogs' lives.
Thus, owing to the above-mentioned factors, the segment is projected to witness robust growth opportunities during the forecast period.
Understand The Key Trends Shaping This Market
Download PDF
North America is Expected to Dominate the Veterinary Intravenous Solutions Market
North America is expected to dominate the market owing to factors such as the rising number of pet owners in the region coupled with higher disposable income. In addition, the increasing trend for preventive veterinary healthcare in the region is another factor expected to support industry expansion. Some of the leading participants offering IV solutions in the region for veterinary care include Merck & Co. Inc., Dechra Veterinary Products, and Sypharma Pty Ltd.
The regional market’s growth is also attributed to the supportive government initiatives for veterinary care and the supportive research environment for veterinary space. For instance, in September 2023, scientists at the University of Saskatchewan from the Western College of Veterinary Medicine received research funding of USD 900,000 from the Natural Sciences and Engineering Council of Canada grant program.
The funding was aimed at improving the overall animal care landscape, including developing novel treatment regimes. Moreover, in September 2023, the Purdue University College of Veterinary Medicine received a grant of USD 3 million to address the shortage of veterinarians in the public and private health sectors. Thus, fostering funding for veterinary research is anticipated to expedite the regional market.
Moreover, the increasing expenditure on the pet industry in the United States is another factor projected to boost industry expansion over the study period. For instance, according to 2024 updated data from the American Pet Products Association, the pet industry expenditures in the United States ramped from USD 136.8 billion in 2022 to USD 147 billion in 2023. This increasing expenditure promises better healthcare for pets, which, in turn, is projected to accelerate industry expansion over the forecast period.
Therefore, owing to the aforementioned factors, the region is anticipated to witness lucrative growth opportunities during the study period.
Get Analysis on Important Geographic Markets
Download PDF
Veterinary Intravenous Solutions Industry Overview
The veterinary intravenous solutions market is fragmented in nature due to the presence of several companies operating globally and regionally. The competitive landscape includes an analysis of a few international and local companies that hold market shares and are well known, including Merck & Co. Inc., Dechra Veterinary Products, Sypharma Pty Ltd, Animalcare, B. Braun SE, Rusoma Laboratories Pvt. Ltd, Aspen Veterinary Resources Ltd, Akina Animal Health, Piramal Pharma Solutions, and Novozymes.
Veterinary Intravenous Solutions Market Leaders
-
Merck & Co., Inc.
-
B. Braun SE
-
Dechra Veterinary Products
-
Animalcare
-
Novozymes
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competiters?
Download PDF
Veterinary Intravenous Solutions Market News
- May 2023: The US Department of Agriculture (USDA) granted a license to Elanco for a therapeutic solution to manage canine parvovirus (CPV). The approved product is an intravenous dose used to treat critical clinical symptoms.
- July 2022: Canine Biologics launched NutriDapt, an adaptive liquid nutrition for needle-feeding injured or critically ill cats, dogs, and puppies. The solution is specifically designed for clinics to offer easy and accurate feeding to patients requiring enteral nutrition.
Veterinary Intravenous Solutions Industry Segmentation
As per the scope of the report, veterinary IV solutions are specialized intravenous fluid therapies designed to maintain hydration, restore electrolyte balance, and deliver medications to animals in clinical settings. These solutions are essential for the treatment of various medical conditions and support optimal health and recovery in animals.
The veterinary IV solutions market is segmented by product, indication, animal type, and end user. Based on the product, the market is segmented into isotonic crystalloids, synthetic colloids, blood products, dextrose solutions, and parenteral nutrition. By indication, the market is segmented as diabetic ketoacidosis, pancreatitis, anthrax, chronic kidney disease, and other indications. By animal type, the market is segmented into companion animals and production animals. By end user, the market is segmented as veterinary hospitals, research institutes, and other end users. The report also covers the market sizes and forecasts for the veterinary intravenous solutions market in major countries across different regions. For each segment, the market size is provided in terms of value (USD).
| By Product | Isotonic Crystalloids | ||
| Synthetic Colloids | |||
| Blood Products | |||
| Dextrose Solutions | |||
| Parenteral Nutrition | |||
| By Indication | Diabetic Ketoacidosis | ||
| Pancreatitis | |||
| Anthrax | |||
| Chronic Kidney Disease | |||
| Other Indications | |||
| By Animal Type | Companion Animals | ||
| Production Animals | |||
| By End User | Veterinary Hospitals | ||
| Research Institutes | |||
| Other End Users | |||
| By Geography | North America | United States | |
| Canada | |||
| Mexico | |||
| Europe | Germany | ||
| United Kingdom | |||
| France | |||
| Italy | |||
| Spain | |||
| Rest of Europe | |||
| Asia-Pacific | China | ||
| Japan | |||
| India | |||
| Australia | |||
| South Korea | |||
| Rest of Asia-Pacific | |||
| Middle East and Africa | GCC | ||
| South Africa | |||
| Rest of Middle East and Africa | |||
| South America | Brazil | ||
| Argentina | |||
| Rest of South America | |||
Need A Different Region or Segment?
Customize Now
Veterinary Intravenous Solutions Market Research FAQs
How big is the Veterinary Intravenous Solutions Market?
The Veterinary Intravenous Solutions Market size is expected to reach USD 1.88 billion in 2025 and grow at a CAGR of 8.23% to reach USD 2.80 billion by 2030.
What is the current Veterinary Intravenous Solutions Market size?
In 2025, the Veterinary Intravenous Solutions Market size is expected to reach USD 1.88 billion.
Who are the key players in Veterinary Intravenous Solutions Market?
Merck & Co., Inc., B. Braun SE, Dechra Veterinary Products, Animalcare and Novozymes are the major companies operating in the Veterinary Intravenous Solutions Market.
Which is the fastest growing region in Veterinary Intravenous Solutions Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Veterinary Intravenous Solutions Market?
In 2025, the North America accounts for the largest market share in Veterinary Intravenous Solutions Market.
What years does this Veterinary Intravenous Solutions Market cover, and what was the market size in 2024?
In 2024, the Veterinary Intravenous Solutions Market size was estimated at USD 1.73 billion. The report covers the Veterinary Intravenous Solutions Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Veterinary Intravenous Solutions Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Veterinary Intravenous Solutions Industry Report
Statistics for the 2025 Veterinary Intravenous Solutions market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Veterinary Intravenous Solutions analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
